| SMNF (n = 19) | MONF (n = 125) | P |
---|---|---|---|
Age, mean (SD), year | 60 (12) | 65 (15) | 0.195 |
Males, No. (%) | 15 (78.9) | 93 (74.4) | 0.783 |
Duration of symptoms, mean (SD), day | 1.7 (1.2) | 3.3 (2.6) | <  0.001* |
Shock during initial visit, No. (%) | 14 (73.7) | 45 (36) | 0.002* |
Comorbidity, No. (%) | |||
 Diabetes mellitus | 4 (21.1) | 48 (38.4) | 0.2 |
 End-stage renal disease | 3 (15.8) | 3 (2.4) | 0.03* |
 Alcoholism | 6 (31.6) | 28 (22.4) | 0.38 |
 Liver cirrhosis | 9 (47.3) | 16 (12.8) | <  0.001* |
 Hepatitis B or Hepatitis C virus | 6 (31.6) | 44 (35.2) | 0.757 |
 Hepatocellular carcinoma | 2 (10.5) | 3 (2.4) | 0.13 |
Total-case mortality, No. (%) | 13 (68.4) | 18 (14.4) | <  0.001* |
 7-day mortality | 9 (69.2) | 1 (5.6) | < 0.001* |
 28-day mortality | 2 (15.4) | 13 (72.2) |  |
 6-month mortality | 2 (15.6) | 4 (22.2) |  |